Literature DB >> 35919629

Anatomy matters: The role of the subject-specific respiratory tract on aerosol deposition - A CFD study.

Jana Wedel1, Paul Steinmann1,2, Mitja Štrakl3, Matjaž Hriberšek3, Yan Cui4, Jure Ravnik3.   

Abstract

The COVID-19 pandemic is one of the greatest challenges to humanity nowadays. COVID-19 virus can replicate in the host's larynx region, which is in contrast to other viruses that replicate in lungs only, i.e. SARS. This is conjectured to support a fast spread of COVID-19. However, there is sparse research in this field about quantitative comparison of virus load in the larynx for varying susceptible individuals. In this regard the lung geometry itself could influence the risk of reproducing more pathogens and consequently exhaling more virus. Disadvantageously, there are only sparse lung geometries available. To still be able to investigate realistic geometrical deviations we employ three different digital replicas of human airways up to the 7 th level of bifurcation, representing two realistic lungs (male and female) as well as a more simplified experimental model. Our aim is to investigate the influence of breathing scenarios on aerosol deposition in anatomically different, realistic human airways. In this context, we employ three levels of cardiovascular activity as well as reported experimental particle size distributions by means of Computational Fluid Dynamics (CFD) with special focus on the larynx region to enable new insights into the local virus loads in human respiratory tracts. In addition, the influence of more realistic boundary conditions is investigated by performing transient simulations of a complete respiratory cycle in the upper lung regions of the considered respiratory models, focusing in particular on deposition in the oral cavity, the laryngeal region, and trachea, while simplifying the tracheobronchial tree. The aerosol deposition is modeled via OpenFOAM\protect \relax \special {t4ht=®} by employing an Euler-Lagrangian frame including steady and unsteady Reynolds Averaged Navier-Stokes (RANS) resolved turbulent flow using the k- ω -SST and k- ω -SST DES turbulence models. We observed that the respiratory geometry altered the local deposition patterns, especially in the laryngeal region. Despite the larynx region, the effects of varying flow rate for the airway geometries considered were found to be similar in the majority of respiratory tract regions. For all particle size distributions considered, localized particle accumulation occurred in the larynx of all considered lung models, which were more pronounced for larger particle size distributions. Moreover, it was found, that employing transient simulations instead of steady-state analysis, the overall particle deposition pattern is maintained, however with a stronger intensity in the transient cases.
© 2022 Published by Elsevier B.V.

Entities:  

Keywords:  Aerosol; CFD; OpenFOAM; SARS-CoV-2

Year:  2022        PMID: 35919629      PMCID: PMC9333481          DOI: 10.1016/j.cma.2022.115372

Source DB:  PubMed          Journal:  Comput Methods Appl Mech Eng        ISSN: 0045-7825            Impact factor:   6.588


  36 in total

1.  Anatomically based three-dimensional model of airways to simulate flow and particle transport using computational fluid dynamics.

Authors:  Caroline van Ertbruggen; Charles Hirsch; Manuel Paiva
Journal:  J Appl Physiol (1985)       Date:  2004-10-22

2.  Quantification of particle deposition in asymmetrical tracheobronchial model geometry.

Authors:  Arpád Farkas; Imre Balásházy
Journal:  Comput Biol Med       Date:  2008-03-11       Impact factor: 4.589

Review 3.  Computational analysis of non-spherical particle transport and deposition in shear flow with application to lung aerosol dynamics--a review.

Authors:  Clement Kleinstreuer; Yu Feng
Journal:  J Biomech Eng       Date:  2013-02       Impact factor: 2.097

Review 4.  Experimental methods for flow and aerosol measurements in human airways and their replicas.

Authors:  Frantisek Lizal; Jan Jedelsky; Kaye Morgan; Katrin Bauer; Jordi Llop; Unai Cossio; Stavros Kassinos; Sylvia Verbanck; Jesús Ruiz-Cabello; Arnoldo Santos; Edmund Koch; Christian Schnabel
Journal:  Eur J Pharm Sci       Date:  2017-08-23       Impact factor: 4.384

Review 5.  Regional aerosol deposition in the human airways: The SimInhale benchmark case and a critical assessment of in silico methods.

Authors:  P Koullapis; S C Kassinos; J Muela; C Perez-Segarra; J Rigola; O Lehmkuhl; Y Cui; M Sommerfeld; J Elcner; M Jicha; I Saveljic; N Filipovic; F Lizal; L Nicolaou
Journal:  Eur J Pharm Sci       Date:  2017-09-07       Impact factor: 4.384

6.  The effect of inlet velocity profile on the bifurcation COPD airway flow.

Authors:  X L Yang; Y Liu; R M C So; J M Yang
Journal:  Comput Biol Med       Date:  2004-12-29       Impact factor: 4.589

Review 7.  Collection, particle sizing and detection of airborne viruses.

Authors:  M Pan; J A Lednicky; C-Y Wu
Journal:  J Appl Microbiol       Date:  2019-06-26       Impact factor: 3.772

8.  Quantitative SARS-CoV-2 Viral-Load Curves in Paired Saliva Samples and Nasal Swabs Inform Appropriate Respiratory Sampling Site and Analytical Test Sensitivity Required for Earliest Viral Detection.

Authors:  Emily S Savela; Alexander Viloria Winnett; Anna E Romano; Michael K Porter; Natasha Shelby; Reid Akana; Jenny Ji; Matthew M Cooper; Noah W Schlenker; Jessica A Reyes; Alyssa M Carter; Jacob T Barlow; Colten Tognazzini; Matthew Feaster; Ying-Ying Goh; Rustem F Ismagilov
Journal:  J Clin Microbiol       Date:  2021-12-15       Impact factor: 5.948

Review 9.  Particle size and pathogenicity in the respiratory tract.

Authors:  Richard James Thomas
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

10.  Characterization of expiration air jets and droplet size distributions immediately at the mouth opening.

Authors:  C Y H Chao; M P Wan; L Morawska; G R Johnson; Z D Ristovski; M Hargreaves; K Mengersen; S Corbett; Y Li; X Xie; D Katoshevski
Journal:  J Aerosol Sci       Date:  2008-11-07       Impact factor: 3.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.